StockholmJun 11 – 14BIO 2026
San DiegoJun 16 – 19ENDO 2026BostonJun 18 – 21ADA 2026San FranciscoJun 19 – 22ESC 2026
LisbonAug 28 – Sep 1EASD 2026
MadridSep 9 – 12ERS 2026
CopenhagenSep 12 – 15ESMO 2026
BerlinSep 12 – 16ECTRIMS 2026BarcelonaSep 17 – 20UEG Week 2026
ViennaOct 3 – 7AHA 2026ChicagoNov 7 – 9ACR 2026Washington DCNov 14 – 19ASH 2026New OrleansDec 12 – 15ACC.27 Together With WCCHoustonApr 10 – 12PastEULAR 2026
LondonJun 3 – 6PastASCO 2026ChicagoMay 29 – Jun 2PastEASL Congress 2026BarcelonaMay 27 – 30PastATS 2026OrlandoMay 15 – 20PastDDW 2026ChicagoMay 2 – 5EHA2026StockholmJun 11 – 14BIO 2026San DiegoJun 16 – 19ENDO 2026BostonJun 18 – 21ADA 2026San FranciscoJun 19 – 22ESC 2026LisbonAug 28 – Sep 1EASD 2026MadridSep 9 – 12ERS 2026CopenhagenSep 12 – 15ESMO 2026BerlinSep 12 – 16ECTRIMS 2026BarcelonaSep 17 – 20UEG Week 2026ViennaOct 3 – 7AHA 2026ChicagoNov 7 – 9ACR 2026Washington DCNov 14 – 19ASH 2026New OrleansDec 12 – 15ACC.27 Together With WCCHoustonApr 10 – 12PastEULAR 2026LondonJun 3 – 6PastASCO 2026ChicagoMay 29 – Jun 2PastEASL Congress 2026BarcelonaMay 27 – 30PastATS 2026OrlandoMay 15 – 20PastDDW 2026ChicagoMay 2 – 5
The Life Science Feed
Podcast
Deep dives with clinicians, researchers, and industry leaders.
All episodes
Yoga Reduces Insomnia, Fatigue, Anxiety in Cancer Survivors
A new study presented at ASCO 2026 demonstrates yoga significantly improves insomnia, fatigue, and anxiety in cancer survivors.
Reassuring Data for High-Efficacy MS Meds in Pregnancy
New data provide reassurance regarding the use of high-efficacy multiple sclerosis therapies during pregnancy, addressing a significant clinical dilemma.
Antihypertensive Use Linked to Higher Fall Risk Across Patient Groups
Antihypertensive medications are associated with an increased fall risk across various patient demographics, necessitating careful risk-benefit assessment.
AI Enhances Oxygen Therapy Titration, Reduces Hypoxia Duration
Artificial intelligence algorithms are demonstrating efficacy in automating oxygen therapy titration, potentially reducing episodes of hypoxia and hyperoxia.
Alternaria Allergy in Youth Signals Persistent Asthma Risk
Early sensitization to Alternaria alternata in children and adolescents is a significant predictor of asthma persistence into adulthood.
Cataract Surgery: 4 Underappreciated Clinical Considerations
Cataract surgery, while common, presents nuances often overlooked in routine practice. This article details four less-known aspects.
mRNA Shot Shows Efficacy Against Influenza-Like Illness
An mRNA vaccine demonstrated efficacy against influenza-like illness, offering a potential new approach to seasonal respiratory virus prevention.
Normal Flatus Frequency: Up to 25 Episodes Daily Considered Typical
Understanding normal flatus frequency is essential for distinguishing physiological gas from symptoms of gastrointestinal pathology. Up to 25 episodes per day is typical.
Stay ahead in
Life Science.
PROTEUS Trial: Neoadjuvant Apalutamide Plus ADT in High-Risk Prostate Cancer
The PROTEUS trial investigated neoadjuvant apalutamide plus ADT for high-risk localised prostate cancer, showing improved pathologic complete response rates.
CAR-T Therapy Versus Bispecific Antibodies
The next phase of CAR-T addresses its biggest limitations: off-the-shelf allogeneic products, in vivo gene delivery, and bispecific antibodies that redirect T cells without any gene engineering. Sarah Mitchell and James Carter explore where the technology is going - and what blood cancer management looks like by 2030.
Small Molecules VS CAR-T In CLL
By the time CAR-T arrived in CLL, the disease had already been transformed by BTK inhibitors and venetoclax. TRANSCEND CLL 004 showed 18% CR in BTKi/venetoclax-refractory disease. Sarah Mitchell and James Carter explore why CLL is harder for CAR-T, where it still has a role - especially in Richter's transformation - and why timing of T cell collection matters.
Moving CAR-T To Earlier Myeloma Lines
1 min readCAR-T Masterstroke Or Biological Chaos?
1 min readDoctor-Patient Communication Improves Treatment Acceptance in Cancer
6 min readTile Radiation for Large Brain Mets: A New Approach at ASCO 2026
6 min readMore Breast Cancer Patients Can Skip Axillary Dissection
6 min readHYRNUO® (Sevabertinib) Shows Efficacy in Advanced Solid Tumours
6 min read
Alcohol and Sugar: A Dual Metabolic Challenge for Patients
Patients consuming alcohol and high-sugar diets face a compounded metabolic risk, impacting liver function and glucose regulation. Clinicians must address both factors.
EASL Congress 2026: Key Trials to Watch in Liver Disease Management
EASL Congress 2026 will feature pivotal trials in NAFLD/NASH, HBV, and HCC, potentially reshaping current treatment paradigms.
Variceal Bleeding Management: EASL 2026 Skills Centre Focuses on Endoscopic and Pharmacological Strategies
EASL 2026 Skills Learning Centre will address variceal bleeding, highlighting current evidence for endoscopic and pharmacological interventions.
EASL 2026: Liver and Spleen Elastography for Fibrosis Assessment
6 min readEASL 2026 Forum: Enhancing Patient-Clinician Communication
6 min readEASL 2026: Alcohol Policy Action Needed for Liver Disease
6 min readA-TANGO Score Refines ACLF Diagnosis, Prognosis in Cirrhosis
6 min readMASLD Diagnosis Faces Barriers Despite 2024 EASL Guidelines
5 min readEASL 2026: Non-invasive Diagnostics Advance Liver Disease Staging
7 min read
Zurich Heart Surgery Scandal: Device Safety Alert Issued
A safety alert has been issued regarding cardiac devices used in Zurich, prompting concerns about patient outcomes and regulatory oversight.
Serum Potassium Concentrations Shape Heart Failure Risk
Optimal serum potassium concentrations in heart failure (HF) are unclear, with new data clarifying the safe range for HFrEF and HFpEF.
Managing Acute Heart Failure And Cardiogenic Shock
Acute decompensated heart failure drives over one million hospital admissions annually. 30-day readmission rates are 25%. When the heart cannot compensate, the tools change entirely - IV diuretics, inotropes, mechanical circulatory support. Sarah Mitchell and James Carter cover ADHF management, cardiogenic shock, and how to prevent the revolving door.
Semaglutide For Obese Heart Failure Patients
1 min readDiabetes Drugs For Stiff Heart Failure
1 min readHow Four Drugs Beat Heart Failure
1 min readTricuspid Valve Surgery Benefits Adults with Systemic Right Ventricle
6 min readDual Plane Block May Cut Opioid Use After Bypass Surgery
6 min readPAHO's HEARTS 2.0 Outlines 38-Step Pathway for Cardio-Renal Care
6 min read
Strategies Emerge to Mitigate Post-GLP-1 Weight Regain
Weight regain following cessation of GLP-1 receptor agonist therapy presents a clinical challenge; emerging strategies focus on sustained pharmacological intervention and lifestyle modification.
Semaglutide Accepted in Scotland for CV Risk Reduction in T2D
Semaglutide has been accepted in Scotland for reducing cardiovascular event risk in adults with type 2 diabetes and established cardiovascular disease.
PCOS Linked to Increased All-Cause Mortality Risk in Women
Polycystic Ovary Syndrome (PCOS) is associated with a significantly elevated risk of all-cause mortality, particularly from cardiovascular disease and diabetes.
BMI Does Not Increase Complication Risk After Reverse Total Shoulder Arthroplasty
4 min read2026 Dyslipidemia Guideline: Utility in Family Medicine Assessed
5 min readThe GLP-1 Muscle Loss Dilemma
1 min readThe Velvet Rope Of Weight Loss Drugs
1 min readGLP-1 Drugs Protect Hearts And Kidneys
1 min readRewiring The Brain To Silence Food Noise
1 min read
CGRP Monoclonal Antibodies for Migraine Linked to Fracture Risk
New data indicate CGRP monoclonal antibodies, used for migraine prevention, may be associated with an increased risk of bone fractures. Clinicians should consider this risk.
Reassuring Data for High-Efficacy MS Meds in Pregnancy
New data provide reassurance regarding the use of high-efficacy multiple sclerosis therapies during pregnancy, addressing a significant clinical dilemma.
Amyloid Therapies Show Limited Cognitive Benefit in Alzheimer's
Amyloid-beta targeting therapies for Alzheimer's disease demonstrate modest effects on cognitive decline, with clinical significance remaining uncertain.
CGRP Inhibitors for Migraine: CV Safety Data Limited in High-Risk Patients
5 min readAmyloid Therapies Show Limited Cognitive Benefit in AD
4 min readPARP1 Deficiency Reduces Amyloid Pathology in Familial AD Model
6 min readBrain Cooling After Thrombectomy: Does Hypothermia Aid LVO Recovery?
6 min readGut Microbiota Signal the Brain via the Vagus Nerve: What GPs Should Know
7 min readLow-Dose Lithium for Cognitive Decline: What the Evidence Actually Shows
7 min read